Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00469391 · ClinicalTrials.gov registry record · Phase 2
Multi-Center Pre-Bariatric Weight Loss Study
A Phase 2 study, sponsored by Morphic Medical.
- Completed
- Registry status
- Phase 2
- Development phase
- 56
- Enrollment target
NCT00469391 is a Phase 2 study that has completed, run by Morphic Medical. The registered enrollment target is 56 participants.
The verdict
NCT00469391, a Phase 2 study, has completed, sponsored by Morphic Medical.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 56 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the safety and efficacy of the GI Sleeve in patients who require weight loss prior to their Bariatric surgery.
Interventions
- PROCEDURE Sham Procedure
- DEVICE GI Sleeve Implantable weight loss device (EndoBarrier)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2007-06 |
| Est. Completion | 2008-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00469391
The ClinicalTrials.gov registry entry for NCT00469391 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Morphic Medical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham Procedure is the first listed.
NCT00469391 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00469391 about?
NCT00469391 is a clinical study titled "Multi-Center Pre-Bariatric Weight Loss Study". The purpose of the study is to evaluate the safety and efficacy of the GI Sleeve in patients who require weight loss prior to their Bariatric surgery.
What is the current status of trial NCT00469391?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 56 participants. The study started on 2007-06. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00469391?
The interventions under investigation include: Sham Procedure (PROCEDURE), GI Sleeve Implantable weight loss device (EndoBarrier) (DEVICE).
Who is sponsoring clinical trial NCT00469391?
This trial is sponsored by Morphic Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.